New combo therapy aims to control brain tumors in lung cancer patients

NCT ID NCT07058428

Recruiting now Disease control Sponsor: Sun Yat-Sen University Cancer Center Source: ClinicalTrials.gov ↗

First seen Nov 18, 2025 · Last updated May 19, 2026 · Updated 28 times

Summary

This study tests whether adding the drug bevacizumab to a precise type of radiation therapy (fractionated stereotactic radiotherapy) can better control brain tumors that have spread from lung adenocarcinoma. About 258 adults with multiple or large brain metastases will receive either radiation alone or radiation plus bevacizumab. The goal is to see if the combination delays tumor growth and reduces side effects.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MULTIPLE BRAIN METASTASES IN LUNG ADENOCARCINOMA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Sun yat-sen University Cancer Center
RECRUITING

Guangzhou, Guangdong, 510000, China

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

MULTIPLE BRAIN METASTASES IN LUNG ADENOCARCINOMA